Aritro Nath - Publications

Affiliations: 
Michigan State University, East Lansing, MI 

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Nath A, Oak A, Chen KY, Li I, Splichal RC, Portis J, Foster S, Walton SP, Chan C. Palmitate-induced IRE1-XBP1-ZEB signaling represses desmoplakin expression and promotes cancer cell migration. Molecular Cancer Research : McR. PMID 33106375 DOI: 10.1158/1541-7786.MCR-19-0480  0.543
2020 Grolmusz VK, Chen J, Emond R, Cosgrove PA, Pflieger L, Nath A, Moos PJ, Bild AH. Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model. Cancer Cell International. 20: 253. PMID 32565737 DOI: 10.1186/S12935-020-01337-1  0.339
2020 O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Nath A, Huo D, Fleming GF, Ingle JN, Abramson VG, Morrow PK, Storniolo AM, Forero A, Van Poznak C, Liu MC, Chang JC, et al. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Research and Treatment. PMID 32378051 DOI: 10.1007/S10549-020-05603-8  0.303
2020 Nath A, Huang RS. Emerging role of long non-coding RNAs in cancer precision medicine. Molecular & Cellular Oncology. 7: 1684130. PMID 31993497 DOI: 10.1080/23723556.2019.1684130  0.337
2019 Pareek S, Nath A, Huang RS. MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeutics. Annals of Translational Medicine. 7: S299. PMID 32016018 DOI: 10.21037/Atm.2019.11.15  0.358
2019 Nath A, Lau EYT, Lee AM, Geeleher P, Cho WCS, Huang RS. Discovering long noncoding RNA predictors of anticancer drug sensitivity beyond protein-coding genes. Proceedings of the National Academy of Sciences of the United States of America. PMID 31548386 DOI: 10.1073/Pnas.1909998116  0.372
2019 Nath A, Geeleher P, Huang RS. Long non-coding RNA transcriptome of uncharacterized samples can be accurately imputed using protein-coding genes. Briefings in Bioinformatics. PMID 30657858 DOI: 10.1093/Bib/Bby129  0.346
2019 Nath A, Lau EY, Lee AM, Geeleher P, Cho WC, Huang RS. Abstract 3578: Comprehensive pharmacogenomic analysis establishes lncRNAs as protein-coding independent biomarker of drug response in human cancers Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3578  0.356
2018 Geeleher P, Nath A, Wang F, Zhang Z, Barbeira AN, Fessler J, Grossman RL, Seoighe C, Stephanie Huang R. Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity. Genome Biology. 19: 130. PMID 30205839 DOI: 10.1186/S13059-018-1507-0  0.394
2018 Nath A, Huang RS. Abstract 3897: Pharmacogenomic landscape of long non-coding RNAs in human cancers Cancer Research. 78: 3897-3897. DOI: 10.1158/1538-7445.Am2018-3897  0.405
2017 Wang F, Chang JT, Zhang Z, Morrison G, Nath A, Bhutra S, Huang RS. Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile. Oncotarget. 8: 115102-115113. PMID 29383145 DOI: 10.18632/Oncotarget.22870  0.369
2017 Geeleher P, Zhang Z, Wang F, Gruener RF, Nath A, Morrison G, Bhutra S, Grossman RL, Huang RS. Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies. Genome Research. PMID 28847918 DOI: 10.1101/Gr.221077.117  0.39
2017 Nath A, Wang J, Stephanie Huang R. Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia. Molecular Diagnosis & Therapy. PMID 28698977 DOI: 10.1007/S40291-017-0292-X  0.339
2017 Geeleher P, Nath A, Huang RS. Institutional Profile: Pharmacogenomic research in R Stephanie Huang Laboratory. Pharmacogenomics. PMID 28290771 DOI: 10.2217/Pgs-2017-0031  0.356
2017 Geeleher P, Zhang Z, Wang F, Nath A, Bhutra S, Grossman R, Huang RS. Abstract 5035: IDWAS: Imputing drug response in large cohorts of cancer patients to discover novel predictive biomarkers Cancer Research. 77: 5035-5035. DOI: 10.1158/1538-7445.Am2017-5035  0.343
2017 Nath A, Geeleher P, Huang RS. Abstract 3481: Leveraging protein coding gene expression profiles to accurately impute lncRNA transcriptome of cancer cells Cancer Research. 77: 3481-3481. DOI: 10.1158/1538-7445.Am2017-3481  0.4
2016 Bilgin B, Nath A, Chan C, Walton SP. Characterization of transcription factor response kinetics in parallel. Bmc Biotechnology. 16: 62. PMID 27557669 DOI: 10.1186/S12896-016-0293-6  0.508
2016 Nath A, Chan C. Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers. Scientific Reports. 6: 18669. PMID 26725848 DOI: 10.1038/Srep18669  0.559
2016 Nath A, Wang F, Lenkala D, LaCroix B, Glavin N, Kipping-Johnson K, Geeleher P, Thirman M, Godley L, Raca G, Larson R, RSH. Abstract 2039: Exploring the longitudinal transcriptomic landscape of tyrosine kinase inhibitor treatment response in chronic myeloid leukemia patients Cancer Research. 76: 2039-2039. DOI: 10.1158/1538-7445.Am2016-2039  0.389
2016 Nath A, Wang F, Lenkala D, LaCroix B, Glavin N, Kipping-Johnson K, Geeleher P, Rich E, Thirman M, Godley L, Raca G, Larson R, Huang R. ID: 26: EXPLORING THE LONGITUDINAL TRANSCRIPTOMIC LANDSCAPE OF TYROSINE KINASE INHIBITOR TREATMENT RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS Journal of Investigative Medicine. 64: 935.2-936. DOI: 10.1136/Jim-2016-000120.50  0.377
2016 Nath A, Chan C. Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers Scientific Reports. 6. DOI: 10.1038/srep18669  0.477
2015 Nath A, Li I, Roberts LR, Chan C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Scientific Reports. 5: 14752. PMID 26424075 DOI: 10.1038/Srep14752  0.517
2015 Kowalsky CA, Faber MS, Nath A, Dann HE, Kelly VW, Liu L, Shanker P, Wagner EK, Maynard JA, Chan C, Whitehead TA. Rapid Fine Conformational Epitope Mapping Using Comprehensive Mutagenesis and Deep Sequencing. The Journal of Biological Chemistry. PMID 26296891 DOI: 10.1074/Jbc.M115.676635  0.42
2015 Nath A, Chan C. Abstract A1-58: Revisiting cancer energetics: Establishing a link between altered fatty-acid metabolism and metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A1-58  0.569
2015 Nath A, Li I, Chan C. Abstract 5157: Elevated uptake of free fatty acids via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma Cancer Research. 75: 5157-5157. DOI: 10.1158/1538-7445.Am2015-5157  0.536
2013 Cho H, Wu M, Zhang L, Thompson R, Nath A, Chan C. Signaling dynamics of palmitate-induced ER stress responses mediated by ATF4 in HepG2 cells. Bmc Systems Biology. 7: 9. PMID 23339444 DOI: 10.1186/1752-0509-7-9  0.633
2013 Nath A, Chan C. Abstract C29: Free fatty acid induced epithelial to mesenchymal transition (EMT) in hepatocellular carcinoma cells Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-C29  0.542
2012 Hijazi H, Wu M, Nath A, Chan C. Ensemble Classification of Cancer Types and Biomarker Identification. Drug Development Research. 73: 414-419. PMID 25221378 DOI: 10.1002/Ddr.21032  0.491
2011 Wang X, Nath A, Yang X, Portis A, Walton SP, Chan C. Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells. Plos One. 6: e28138. PMID 22132232 DOI: 10.1371/Journal.Pone.0028138  0.612
2010 Yang X, Nath A, Opperman MJ, Chan C. The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells. Molecular Biology of the Cell. 21: 3449-58. PMID 20685959 DOI: 10.1091/Mbc.E10-06-0481  0.59
Show low-probability matches.